Avac Event
AVAC’s Mitchell Warren and Stacey Hannah will join Infectious Disease Alliance (IDA) and Esperity for a webinar on how patient-driven collaboration is enhancing the design, implementation, and impact of clinical trials in the field of infectious diseases. AVAC colleagues will share insights from AVAC’s 30 years of community engagement in HIV prevention.
Avac Event
Join an engaging session on the Dual Prevention Pill (DPP), featuring Kate Segal (AVAC), Barbara Friedland (Population Council), and Wawira Nyagah (AVAC). Speakers will highlight the product pipeline, the regulatory pathway, and the implementation agenda ahead—followed by a panel discussion with leading experts driving progress in MPTs.
Avac Event
This webinar will provide participants with scientific, policy, funding and community highlights from IAS 2025, the 13th IAS Conference on HIV Science, held in Kigali, Rwanda, in July. Attendees will gain a clearer understanding of the latest trends and emerging priorities in the global HIV response and hear reflections from stakeholders, including community voices.
Moderators
Speakers
Avac Event
This 60-minute webinar is intended for communities, providers, policy makers and advocates for PrEP, HIV prevention and HIV testing. We will provide an overview of the key takeaways and new guidance from newly released Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis.
Thursday 28 August 2025 at 13:00 – 14:00 Geneva-time
Times in your location: 7:00 EDT / 12:00 WAT / 13:00 CEST / 13:00 SAST / 14:00 EEST / 16:30 IST / 18:00 ICT / 19:00 PHST
After registering, you will receive a confirmation email containing information about joining the webinar.
This is the first webinar in a three-part series:
Further details about these webinars will be shared soon!
Avac Event
Join the International Community of Women Living with HIV Eastern Africa (ICWEA) to discuss the dapivirine vaginal ring, lenacapavir, and cabotegravir. Moderated by Lillian Mworeko and Dr. Lilian Benjamain Mwakyosi, speakers include:
Avac Event
We are excited to invite you to our next TOWN HALL 📣 happening on Tuesday, August 12th at 10 AM EST!
We will be launching two critical resources:
Gain insights from leading voices driving innovation in HIV prevention:
Together, we’ll explore what’s next for long-acting PrEP access, readiness, and demand among key populations globally.
👉 Click the registration link to register now!
Avac Event
This is an ongoing series which occurs on the first Monday of alternating months and moderated by Drs. Patrick Sullivan (Emory Center for AIDS Research) and Kenneth Mayer (Harvard University Center for AIDS Research).
In August, AVAC Executive Director Mitchell Warren presented. Watch the presentation below. Download his slides.
Avac Event
Pre-exposure prophylaxis (PrEP) has emerged as a critical tool in the global HIV prevention response. Despite its proven efficacy, global uptake of oral PrEP has been slower than anticipated, falling short of UNAIDS’ 2025 targets. However, several countries have successfully scaled up oral PrEP, and in the process learnt significant lessons, many of which they are already applying to introduce newer long-acting (LA) PrEP options such as the dapivirine vaginal ring (DVR) and injectable cabotegravir (CAB), and in planning for the introduction of the recently FDA approved twice yearly injectable lenacapavir (LEN).
This webinar aimed to increase momentum around ARV-based HIV prevention by highlighting key opportunities and challenges in scaling up PrEP. Drawing on findings from AVAC’s recent report, “Getting PrEP Rollout Right This Time: Lessons from the Field” (June 2025), the session shared country-level insights and effective interventions to support PrEP adherence and uptake. It reinforced the need for robust, context-driven strategies to accelerate equitable access to these critical prevention tools.
The specific objectives of this webinar were:
Avac Event
While the HIV prevention buffet will soon offer a second form of long acting injectable PrEP, ensuring access to all those who can benefit requires innovations in service delivery such as task shifting. In the United States, two Federally Qualified Health Centers (FQHCs) have implemented programming that has expanded clinic capacity, resulting in more individuals being able to choose long acting injectable PrEP. We also heard about innovative efforts to expand PrEP access in South Africa and learned what it takes to integrate task shifting for long-acting PrEP injection programs. We discussed other ways we can collectively innovate to support expanded, sustainable access to all forms of PrEP.
Speakers:
Moderator:
Materials:
Avac Event
The International AIDS Society (IAS) is partnering with the International Society for Vaccines (ISV) to host a virtual mini-symposium on HIV vaccine research and development (R&D). Be sure to take up this unique opportunity to engage with cutting-edge research and contribute to the ongoing dialogue around HIV vaccine development.
Event speakers
Part of ISV’s quarterly Mini Symposia series, this session brings together global leaders in HIV vaccine R&D to share the latest research, challenges and breakthroughs in the field.
Join us in a discussion with: